Skip to main content

20 publications

Name Date Type Actions

Vétoquinol continues to launch reference products

Lure (France), December 16, 2013 – In line with its strategy of developing products targeting fast-growing markets, the Vétoquinol Group expands its Flexadin® range world-wide and launches Zylkène® in the United States.

16/12/2013 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - November 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

11/12/2013 Voting rights

Monthly information regarding the total number of voting rights and shares making of the share capital - October 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

10/12/2013 Voting rights

2013 3rd quarter sales show organic growth

Vétoquinol generated sales of €74.0 million in the 3rd quarter of 2013, a drop of 0.1% based on reported data, and a 4.4% increase at constant exchange rates.

24/10/2013 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - September 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

10/10/2013 Voting rights

Monthly information regarding the total number of voting rights and shares making of the share capital - august 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

18/09/2013 Voting rights

The reference products demonstrate solid growth

Lure (France), August 29, 2013 – At its meeting on August 27, 2013, the Vétoquinol S.A. Board of Directors reviewed the Group’s results, and approved the financial statements for the first six months of 2013.

29/08/2013 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - july 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

23/08/2013 Voting rights

Q2 2013 sales

Vétoquinol posted Q2 2013 sales of €70 million, up 0.3% on reported figures and up 1.4% like for like.

16/07/2013 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - june 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

08/07/2013 Voting rights